FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to the field of pharmaceutics; it can be used in cancer treatment. A pharmaceutical composition for cancer treatment contains an ionic compound, in which two compounds selected from ascorbic acid, dichloroacetic acid, and lactate are combined with Ca2+ as an active ingredient. A food composition containing the specified ionic compound and pharmaceutical compositions containing the specified ionic compound are also proposed for suppression of cancer metastasis and for prevention or reduction in fatigue related to cancer.
EFFECT: compositions provide for an improved therapeutic effect due to disorders of cancer cell metabolism, effectively inhibit proliferation, invasion, and metastasis of cancer cells.
12 cl, 22 dwg, 10 tbl, 5 ex
Title |
Year |
Author |
Number |
COMPOUNDS FOR TREATING CANCER |
2008 |
- Karlsson Jan Olof G.
- Kurts Tino
- Andersson Rol'F
|
RU2491282C2 |
PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR TREATMENT OF CANCER |
2014 |
- Kijono Kunikhiko
- Onisi Kendzi
- Nagakhama Yasukharu
- Vatanabe Takasi
|
RU2671488C2 |
ANTICANCER COMPOSITION |
2019 |
- Su, Man-Chkhul
- Dzhon, Iyn
- Kim, Yn Chi
- Dzhon, Chzhe In
|
RU2789245C2 |
APPLICATION OF 3-(R)-[3-(2-METHOXYPHENYLTHIO)-2-(S)-METHYLPROPYL]AMINO-3,4-DIHYDRO-2H-1,5-BENZOXATHIEPIN FOR TREATMENT OF CANCER AND, PARTICULARLY, FOR PREVENTION AND/OR TREATMENT OF CANCER METASTASIS |
2012 |
- Vashe Bernar
- Le Gran Bruno
|
RU2626511C2 |
APILIMOD COMPOSITIONS AND METHODS OF USING THEM IN TREATING COLORECTAL CANCER |
2015 |
- Bikharri Nil
- Gejl Sofiya
- Landrette Shon
- Bekett Pol
- Konrad Kris
- Syuj Tyan
- Ernandes Marilens
- Rotberg Dzhonatan M.
- Likhenshtejn Khenri
|
RU2739992C2 |
SYSTEMS, METHODS AND COMPOSITIONS FOR CANCER TREATMENT |
2012 |
|
RU2644635C2 |
COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER, INCLUDING A VESSEL-DESTROYING AGENT AND A TAXANE COMPOUND |
2019 |
|
RU2761826C1 |
RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS |
2018 |
|
RU2811734C2 |
SYGETHIN-BASED PHARMACEUTICAL STRUCTURE FOR OSTEOPOROSIS PREVENTION AND TREATMENT (VERSIONS) |
2007 |
- Arinbasarov Mikhail Utevlevich
- Kashparov Konstantin Ivanovich
- Kogan Vladimir Il'Ich
- Mezhburd Evgenij Vol'Fovich
|
RU2356546C1 |
COMBINED DRUGS CONTAINING PKM2 AND HMGB1 MODULATORS |
2016 |
|
RU2768186C2 |